Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma

2016 ◽  
Vol 254 (9) ◽  
pp. 1787-1792 ◽  
Author(s):  
Ira Seibel ◽  
Dino Cordini ◽  
Annette Hager ◽  
Johanna Tillner ◽  
Aline I. Riechardt ◽  
...  
Keyword(s):  
Risk Factors ◽  
Proton Beam ◽  
Uveal Melanoma ◽  
Optic Neuropathy ◽  
Proton Beam Therapy ◽  
Radiation Retinopathy ◽  
Predictive Risk

Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome

2015 ◽  
Vol 160 (4) ◽  
pp. 628-636 ◽  
Author(s):  
Ira Seibel ◽  
Dino Cordini ◽  
Matus Rehak ◽  
Annette Hager ◽  
Aline I. Riechardt ◽  
...  
Keyword(s):  
Risk Factors ◽  
Local Recurrence ◽  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Beam Therapy ◽  
Primary Proton ◽  
Melanoma Risk

Phantom vision after eye removal: prevalence, features and related risk factors

2021 ◽  
pp. bjophthalmol-2021-319091
Author(s):  
Arnaud Martel ◽  
Stephanie Baillif ◽  
Pierre Thomas ◽  
Fabien Almairac ◽  
Olivier Galatoire ◽  
...  
Keyword(s):  
Risk Factors ◽  
Retinal Detachment ◽  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Beam Therapy ◽  
Visual Hallucinations ◽  
Eye Pain ◽  
Related Risk ◽  
Anxiety Depression ◽  
Over Time

AimPhantom eye syndrome is a poorly understood and underestimated complication of eye removal (ER). Seeing with the amputated eye, referred to as phantom vision (PV), is undoubtedly the most intriguing and confusing complication experienced by anophthalmic patients. The aim of the study was to assess PV prevalence, clinical features and risk factors after ER.MethodsA multicentric questionnaire-based study was conducted between April 2016 and July 2017. Patients >18 years who underwent ER >3 months ago had a socket examination before inclusion. Data recorded included patients’ demographics, and preoperative, surgical and postoperative features.ResultsOne hundred patients (53 men) with a mean age of 65.1 years (29–92; SD=13.0) were included. ER indications were: uveal melanoma (n=24, 24%), trauma (n=20, 20%), retinal detachment (n=20, 20%), glaucoma (n=14, 14%) and endophthalmitis (n=12, 12%). Thirty (30%) patients experienced PV. Elementary and complex visual hallucinations were experienced by 80% and 20% of patients, respectively. PV usually appeared within the first postoperative month and tended to decrease over time. Risk factors for PV were the preoperative use of proton beam therapy (p=0.006), uveal melanoma (p=0.014), enucleation (p=0.015), anxiety with a Hospital and Anxiety Depression (HAD) score ≥8 (p=0.042), depression with a HAD score ≥8 (p=0.030), phantom eye pain (p=0.044) and phantom eye sensations (p=0.002).ConclusionPV was reported by one-third of our patients. Despite being widely misunderstood, ophthalmologists and neurologists should be aware of this complication to adequately reassure patients.

Tumor and Dosimetric Predictors of Long-Term Visual Outcomes After Proton Beam Therapy of Uveal Melanoma

2014 ◽  
Vol 90 (1) ◽  
pp. S305 ◽  
Author(s):  
A.L. Polishchuk ◽  
D.H. Char ◽  
V. Weinberg ◽  
I.K. Daftari ◽  
T.B. Cole ◽  
...  
Keyword(s):  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Beam Therapy ◽  
Visual Outcomes

Uveal Melanoma Recurrence After Fractionated Proton Beam Therapy: Comparison of Survival in Patients Treated With Reirradiation or With Enucleation

2011 ◽  
Vol 79 (3) ◽  
pp. 842-846 ◽  
Author(s):  
Laura Marucci ◽  
Marek Ancukiewicz ◽  
Anne Marie Lane ◽  
John M. Collier ◽  
Evangelos S. Gragoudas ◽  
...  
Keyword(s):  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Beam Therapy

Local Recurrence After Uveal Melanoma Proton Beam Therapy: Recurrence Types and Prognostic Consequences

2013 ◽  
Vol 85 (5) ◽  
pp. 1218-1224 ◽  
Author(s):  
Jean-Pierre Caujolle ◽  
Vincent Paoli ◽  
Emmanuel Chamorey ◽  
Celia Maschi ◽  
Stéphanie Baillif ◽  
...  
Keyword(s):  
Local Recurrence ◽  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Beam Therapy

Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma

2016 ◽  
Vol 168 ◽  
pp. 31-39 ◽  
Author(s):  
Ira Seibel ◽  
Annette Hager ◽  
Aline I. Riechardt ◽  
Anja M. Davids ◽  
Alexander Böker ◽  
...  
Keyword(s):  
Proton Beam ◽  
Uveal Melanoma ◽  
Corticosteroid Treatment ◽  
Proton Beam Therapy

Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy

2017 ◽  
Vol 256 (2) ◽  
pp. 411-420 ◽  
Author(s):  
Amir Mahdjoubi ◽  
Marie Najean ◽  
Stéphanie Lemaitre ◽  
Sylvain Dureau ◽  
Rémi Dendale ◽  
...  
Keyword(s):  
Proton Beam ◽  
Uveal Melanoma ◽  
Intravitreal Bevacizumab ◽  
Proton Beam Therapy ◽  
Neovascular Glaucoma
Sign in / Sign up

Export Citation Format

Share Document